Lea Payen-Gay

10PUBLICATIONS
27CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 31, 2025
Pharmacological effects of osimertinib on a chicken chorioallantoic membrane xenograft model with the EGFR exon-19-deleted advanced NSCLC mutation.

David Barthélémy, Arnaud Vigneron, Xavier Rousset

|Oct 25, 2024
Correction: Barthélémy et al. Direct Comparative Analysis of a Pharmacogenomics Panel with PacBio Hifi® Long-Read and Illumina Short-Read Sequencing. J. Pers. Med. 2023, 13, 1655.

David Barthélémy, Elodie Belmonte, Laurie Di Pilla

|May 31, 2024
Intraperitoneal Nivolumab after Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: A Phase I Study with Expansion Cohort.

Pauline Corbaux, Gilles Freyer, Olivier Glehen

|Dec 23, 2023
Direct Comparative Analysis of a Pharmacogenomics Panel with PacBio Hifi® Long-Read and Illumina Short-Read Sequencing.

David Barthélémy, Elodie Belmonte, Laurie Di Pilla

|Aug 26, 2023
Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling.

Emmanuel Grolleau, Julie Candiracci, Gaelle Lescuyer

|Mar 11, 2023
Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays.

David Barthelemy, Gaelle Lescuyer, Florence Geiguer

Pageof 2

Frequent Collaborators

4 joint publications

David Barthelemy

3 joint publications

Julie Balandier

2 joint publications

Jessica Garcia

2 joint publications

Anne-Sophie Wozny